Story

Tesla Options Market Prices in 5.7% Post-Earnings Move

ENTHMSVIIDZHZH-TWJAKOHI
Jul 15, 20261 min read
Tesla Options Market Prices in 5.7% Post-Earnings Move

Summary

The options market is pricing in a potential 5.7% swing for Tesla (TSLA) stock following its July 22 earnings report, according to Bloomberg data. A review of the past eight quarters shows the stock's actual move has often been more muted than implied.

Text size
Background

The options market is pricing in a potential 5.7% swing for Tesla Inc. (NASDAQ:TSLA) shares following the company's upcoming earnings report on July 22. This figure, based on data compiled by Bloomberg, reflects investor expectations for volatility surrounding the electric vehicle maker's financial results.

Market Expectations

Tesla is scheduled to release its quarterly earnings after the market closes on July 22. The 5.7% implied move is derived from the pricing of options contracts that expire shortly after the announcement and represents the market's consensus on the potential magnitude of the stock's price change, either up or down.

This metric, known as implied volatility, serves as a key benchmark for traders. It quantifies the level of uncertainty and potential risk anticipated by the market ahead of a major catalyst like an earnings release.

Historical Performance vs. Implied Move

Sample IUX Markets – In-articleAd

A review of Tesla's last eight earnings reports shows that the stock's actual move has often differed from what the options market had priced in. The stock's price change exceeded the market's expectation in only two of the last eight quarters, according to the data.

This historical record suggests a tendency for realized volatility to be lower than what options traders had anticipated. For instance, following the April 22 report, the stock moved just 2.6% compared to an implied 4.9% move. However, significant outperformance is also possible, as seen in the two instances where the actual move was larger:

  • October 23, 2024: The stock surged 18.6%, more than double the 7.0% move implied by options.
  • July 23, 2024: Shares dropped 14.5%, significantly outpacing the 8.3% implied move.

Read next

More on Stocks
Shenzhen-Listed Jingxin Pharmaceutical Refiles for Hong Kong IPO

Stocks

Shenzhen-Listed Jingxin Pharmaceutical Refiles for Hong Kong IPO

Sep 20, 2026

Zhejiang Jingxin Pharmaceutical Co., Ltd. (002020.SZ) has resubmitted its application for a main board listing on the Hong Kong Stock Exchange, aiming to secure a dual listing to access international capital. The company specializes in drugs for central nervous system and cardiovascular diseases.

Back to latest news

LATEST